| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_21a837b6e77981109aa7871f1ca8c2fa |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-53 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-20 |
| filingDate |
2016-07-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2a0ddea93b18ba80222a965fb8aecd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_159d402f2799f59868b3a7a986cfcac6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_476892a82e98f456ed54a7b357d0e82e |
| publicationDate |
2017-01-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2017010330-A1 |
| titleOfInvention |
Anti-hepatitis b virus drug |
| abstract |
Provided is a novel anti-hepatitis B virus (HBV) drug that has a different function mechanism (a target molecule) from existing medicines.nThe anti-HBV drug comprises a compound represented by formula (I), a tautomer thereof or a salt or solvate of the same [in formula (I), R 1 , R 2 and R 3 are the same or different and represent an optionally substituted C 1-6 alkyl group or an optionally substituted aromatic group]. |
| priorityDate |
2015-07-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |